Effect of the Inhaled Triple Therapies Over the Small Airway in Patients With Chronic Obstructive Pulmonary Disease or Chronic Bronchitis Without Obstruction Secondary to Biomass Exposure: Randomized Controlled Clinical Trial Phase IV
Latest Information Update: 03 Sep 2024
Price :
$35 *
At a glance
- Drugs Beclometasone/formoterol/glycopyrrolate (Primary) ; Budesonide/formoterol/glycopyrrolate (Primary) ; Fluticasone furoate/umeclidinium/vilanterol (Primary) ; Umeclidinium/vilanterol (Primary)
- Indications Chronic bronchitis; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 03 Sep 2024 New trial record